305results about How to "Avoid treatment" patented technology

A method is provided for predicting an onset of an asthma attack. The method includes sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the asthma attack at least in part responsively to the sensed parameter. Also provided is a method for predicting an onset of an episode associated with congestive heart failure (CHF), including sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the episode at least in part responsively to the sensed parameter. Other embodiments are also described.

A method is provided for predicting an onset of an asthma attack. The method includes sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the asthma attack at least in part responsively to the sensed parameter. Also provided is a method for predicting an onset of an episode associated with congestive heart failure (CHF), including sensing at least one parameter of a subject without contacting or viewing the subject or clothes the subject is wearing, and predicting the onset of the episode at least in part responsively to the sensed parameter. Other embodiments are also described.

The invention relates to methods for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation in tissue of an antigen-sensitized mammal host by delivering an immunostimulatory oligonucleotide to the host. In addition, methods for using the immunostimulatory oligonucleotides to boost a mammal host's immune responsiveness to a sensitizing antigen (without immunization of the host by the antigen) and shifting the host's immune responsiveness to a Th1 phenotype to achieve various therapeutic ends are provided. Kits for practicing the methods of the invention are also provided.

The present invention provides orthotic devices for use in managing the treatment and prevention of lower extremity injuries, including foot ulcers. In various aspects, the present invention provides foot-worn orthotics which provide for improved compliance monitoring, and methods of their manufacture and use.

Systems and methods for aiding individuals to complete tasks of daily living are provided. The situationally aware system comprises a controller, sensors, and effectors. The controller may include a program that describes a sequence of steps the user should perform to accomplish the task. In response to the information from the sensors and the user's compliance with the steps of the sequence, the controller instructs the effector(s) to relay at least one instructional cue to the user to aid in the performance of the task. The instructional cue may range from a simple blinking light, to detailed audio and/or visual instructions, to relaying a reward for the completion of the task. The instructional cue may also instruct the user to refrain from performing a task. The system is programmable, configurable, and may interface to the Internet.

The present invention relates to use of ornithine in the manufacture of a medicament for use in combination with at least one of phenylacetate and phenylbutyrate for preventing or treating liver decompensation or hepatic encephalopathy. The invention also relates to use of at least one of phenylacetate and phenylbutyrate in the manufacture of a medicament for use in combination with ornithine for preventing or treating liver decompensation or hepatic encephalopathy.

A method is provided for predicting an onset of a clinical episode, the method including sensing breathing of a subject, determining at least one breathing pattern of the subject responsively to the sensed breathing, comparing the breathing pattern with a baseline breathing pattern, and predicting the onset of the episode at least in part responsively to the comparison. Other embodiments are also described.

A system for monitoring at least one physiological parameter of a human subject. The system of the present invention features a device with which the human subject regularly interacts, and which is connected to the computational device of the human subject for automatic collection of at least one physiological parameter which is also of medical interest. The device features at least one physiological sensor for collecting the measurement of the physiological parameter. The computational device of the human subject then preferably operates a software program to analyze the data which is collected, in order for the human subject to receive an alert when necessary. Alternatively or additionally, the collected data is sent to a remote computational device which is in communication with the computational device of the human subject for analysis. Optionally, the present invention enables the human subject to receive an alert if a deterioration in the physiological condition of the human subject is detected, thereby enabling the human subject to start preventive medical treatment with trained medical personnel as soon as possible. Thus, the awareness of the human subject about any incipient medical problem is immediately improved, which may result in an increased probability of being able to successfully treat and/or otherwise ameliorate those problems.

Topical ointment for preventing and treating diaper rash are disclosed. The topical ointments comprise an emollient, a structurant, a rheology enhancer, and other optional components. In one preferred embodiment, the topical ointment comprises a particulate material such as zinc oxide as an optional component.

This invention relates to an automated process for efficiently treating an aqueous system with chlorine dioxide. The process results in high efficiency yields of chlorine dioxide on a continuous basis by minimizing the waste of precursor chemicals. Additionally, the process creates less environmental stress because the formation of unwanted by-products is minimized. The level of chlorine dioxide in the aqueous system treated and other parameters of the process are monitored and adjusted automatically to maintain them within acceptable levels.

A method for adapting motion profiles of a plurality of individually controllable transport elements for transporting containers in a container treatment system along a transport path, wherein the plurality of transport elements are movably arranged along the transport path, the method includes the following steps: determining a treatment state of at least one container carried along by a first transport element, and/or determining an operational state of at least one first container treatment unit which is arranged downstream with respect to a position of the first transport element along the transport path, wherein the first transport element is moved by an open- and/or closed-loop control unit of the container treatment system as part of a stream of transport elements, and wherein the motion profile of the first transport element is adapted by the open- and/or closed-loop control unit in response to the determined treatment state and/or the determined operational state.

Muscle toner is a progressive resistance fitness device to simultaneously activate muscle groups in arms, shoulders, upper chest, upper back, and neck areas. It strengthens muscle fibers, removes muscle tension, and restores motion to joints. Exercising with muscle toner is effective in the prevention and treatment of snoring, tension headaches, neck, and shoulder pains.

Provided is a chromium-free metal surface treatment agent excellent in rust inhibitive performance which can be used in a surface treatment of metal products, in particular, galvanized metal products. The metal surface treatment agent consists essentially of a siliceous binder solution comprising water and/or alcohol as a solvent, and the concentration of the silica component is 8 to 25% by weight. In particular, a metal surface treatment agent containing an alcoholic solution of alkoxysilane oligomer having a weight averaged molecular weight of 1000 to 10000, which is obtained by hydrolyzed condensation polymerization of alkoxysilane, can suppress the occurrence of white rusting for a long time. It is preferred that 3 to 25 parts by weight of a dispersed nano-sized titanium dioxide powder having an average primary particle size of not more than 70 nm, per 100 parts by weight of the silica component be suspended in the siliceous binder solution. The rust inhibitive performance of the metal surface treatment agent can be further improved by using an alcohol-soluble polyvinyl butyral resin and by adding a silane coupling agent having a vinyl or epoxy group as a functional group, in combination with a dispersed nano-sized powder of titanium dioxide.

The invention relates to a specialized subpopulation of natural killer cells that have enhanced effector functions and the potential to kill malignant tumor cells or infected cells when the natural killer cells are exposed to an antibody bound to the tumor cells or the infected cells.